Extension to the use of tolerance intervals for the assessment of individual bioequivalence
From MaRDI portal
Publication:4298668
DOI10.1080/10543409408835071zbMath0800.62733OpenAlexW2080913272WikidataQ53789929 ScholiaQ53789929MaRDI QIDQ4298668
James D. Esinhart, Vernon M. Chinchilli
Publication date: 18 August 1994
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10543409408835071
Related Items (7)
A Generalized Correlation Coefficient for the General Two-Treatment Crossover Design ⋮ An Alternative Method for Estimating the Variance Components in a Replicated Crossover Study ⋮ The assessment of individual and population bioequivalence ⋮ Individual bioequivalence—a regulatory update ⋮ Some issues for the consideration of individual bioequivalence ⋮ On tier method for assessment of individual bioequivalence ⋮ BIOEQUIVALENCE REVIEW FOR DRUG INTERCHANGEABILITY
Cites Work
This page was built for publication: Extension to the use of tolerance intervals for the assessment of individual bioequivalence